Sudhir C Sarangi
Overview
Explore the profile of Sudhir C Sarangi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh R, Sarangi S, Singh S, Tripathi M
Seizure
. 2022 Sep;
101:253-261.
PMID: 36116284
Background: Available anti-seizure medications (ASMs) target the symptomatology of the disease rather than any significant disease/epileptogenesis modifying actions. There are critical concerns of drug resistance and seizure recurrence during epilepsy...
2.
Sarangi S, Kumar S, Tripathi M, Kaleekal T, Singh S, Gupta Y
Indian J Pharmacol
. 2022 Mar;
54(1):24-32.
PMID: 35343204
Objectives: Antiepileptic-drug (AED) serum level and inflammatory biomarkers are primarily monitored/assessed during epilepsy treatment for effective seizure control; however, their correlation with seizure recurrence (SR) following AED-tapering has not been...
3.
Maharshi V, Kumar V, Sarangi S, Upadhyay A, Kumar A
J Basic Clin Physiol Pharmacol
. 2021 Dec;
33(5):625-632.
PMID: 34914338
Objectives: The fact that oxidative stress plays an important role in the pathogenesis of various pulmonary diseases is supported by the beneficial effect of antioxidants. It is also well known...
4.
Sarangi S, Kaur N, Tripathi M
Saudi Pharm J
. 2020 Nov;
28(10):1228-1237.
PMID: 33132717
Objective: Newer antiepileptic drugs (AEDs) are expected to have less adverse effects (AEs) and drug interactions as compared to conventional AEDs but the high cost is the major limitation for...
5.
Sarangi S, Kaur N, Tripathi M, Gupta Y
Neurol India
. 2018 Sep;
66(5):1427-1433.
PMID: 30233018
Context: This study investigated the cost variation among neuropsychiatric drugs prevalent in the Indian market with reference to the National List of Essential Medicines (NLEM, 2015). Aims: To promote the...
6.